Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
EIC Pathfinder for the development of a novel treatment for severe chronic neuropathic pain
| Reference number | 2024-04086 |
| Coordinator | CombiGene AB |
| Funding from Vinnova | SEK 0 |
| Project duration | January 2025 - May 2025 |
| Status | Completed |
| Venture | Global cooperation 2024 |
| Call | Planning grant for international proposal 2024 |
Last updated 14 January 2025
Reference number 2024-04086
